These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 34304673)
1. Fertility preservation immediately after therapeutic abortion results in multiple normal follicular growth with the absence of mature oocytes due to early luteinization: a case report and literature review. Hamada H; Hayama T; Ijuin A; Miyakoshi A; Kasai M; Tochihara S; Saito M; Nishi M; Ueno H; Yamamoto M; Komeya M; Yumura Y; Sakakibara H; Miyagi E; Murase M Gynecol Endocrinol; 2021 Nov; 37(11):1050-1053. PubMed ID: 34304673 [TBL] [Abstract][Full Text] [Related]
2. Gonadotropin-releasing hormone agonist trigger increases the number of oocytes and embryos available for cryopreservation in cancer patients undergoing ovarian stimulation for fertility preservation. Pereira N; Kelly AG; Stone LD; Witzke JD; Lekovich JP; Elias RT; Schattman GL; Rosenwaks Z Fertil Steril; 2017 Sep; 108(3):532-538. PubMed ID: 28865552 [TBL] [Abstract][Full Text] [Related]
3. Suboptimal response to GnRH-agonist trigger during oocyte cryopreservation: a case series. Russo M; Liu K; Chan C Reprod Biol Endocrinol; 2020 Jun; 18(1):59. PubMed ID: 32503566 [TBL] [Abstract][Full Text] [Related]
4. Bypassing physiological puberty, a novel procedure of oocyte cryopreservation at age 7: a case report and review of the literature. Azem F; Brener A; Malinger G; Reches A; Many A; Yogev Y; Lebenthal Y Fertil Steril; 2020 Aug; 114(2):374-378. PubMed ID: 32386868 [TBL] [Abstract][Full Text] [Related]
5. Fertility preservation with random-start controlled ovarian stimulation and embryo cryopreservation for early pregnancy-associated breast cancer. Pereira N; Kligman I; Hunt R; Kopparam R; Wahmann B; Rosenwaks Z Gynecol Endocrinol; 2019 Mar; 35(3):214-216. PubMed ID: 30403906 [TBL] [Abstract][Full Text] [Related]
6. Follicular growth but absence of oocyte and cumulus maturation during ovarian stimulation in the days following surgical abortion: a case report. Cohade C; Moreau J; Gatimel N; Gladieff L; Parinaud J; Leandri R Gynecol Endocrinol; 2017 Sep; 33(9):680-681. PubMed ID: 28452561 [TBL] [Abstract][Full Text] [Related]
7. Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy. Danis RB; Pereira N; Elias RT Curr Pharm Biotechnol; 2017 Nov; 18(8):609-613. PubMed ID: 28786354 [TBL] [Abstract][Full Text] [Related]
8. A simplified universal approach to COH protocol for IVF: ultrashort flare GnRH-agonist/GnRH-antagonist protocol with tailored mode and timing of final follicular maturation. Orvieto R J Ovarian Res; 2015 Nov; 8():69. PubMed ID: 26536862 [TBL] [Abstract][Full Text] [Related]
9. Effects of cancer stage and grade on fertility preservation outcome and ovarian stimulation response. Volodarsky-Perel A; Cohen Y; Arab S; Son WY; Suarthana E; Dahan MH; Tulandi T; Buckett W Hum Reprod; 2019 Mar; 34(3):530-538. PubMed ID: 30689898 [TBL] [Abstract][Full Text] [Related]
15. Successful controlled ovarian stimulation despite elevated hCG levels after first-trimester abortion in the context of fertility preservation. Goeckenjan M; Rösner S; Toth B; Strowitzki T; Germeyer A Gynecol Endocrinol; 2013 Nov; 29(11):960-2. PubMed ID: 23952105 [TBL] [Abstract][Full Text] [Related]
16. Ovarian response and follow-up outcomes in women diagnosed with cancer having fertility preservation: Comparison of random start and early follicular phase stimulation - cohort study. Muteshi C; Child T; Ohuma E; Fatum M Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():10-14. PubMed ID: 30227359 [TBL] [Abstract][Full Text] [Related]
17. Oocyte cryopreservation for fertility preservation in postpubertal female children at risk for premature ovarian failure due to accelerated follicle loss in Turner syndrome or cancer treatments. Oktay K; Bedoschi G J Pediatr Adolesc Gynecol; 2014 Dec; 27(6):342-6. PubMed ID: 25214440 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of controlled ovarian stimulation using GnRH antagonist protocols for emergency fertility preservation in young women with breast cancer-a prospective nationwide Swedish multicenter study. Marklund A; Eloranta S; Wikander I; Kitlinski ML; Lood M; Nedstrand E; Thurin-Kjellberg A; Zhang P; Bergh J; Rodriguez-Wallberg KA Hum Reprod; 2020 Apr; 35(4):929-938. PubMed ID: 32313940 [TBL] [Abstract][Full Text] [Related]
19. Dual trigger for final oocyte maturation improves the oocyte retrieval rate of suboptimal responders to gonadotropin-releasing hormone agonist. Lu X; Hong Q; Sun L; Chen Q; Fu Y; Ai A; Lyu Q; Kuang Y Fertil Steril; 2016 Nov; 106(6):1356-1362. PubMed ID: 27490046 [TBL] [Abstract][Full Text] [Related]
20. Optimal timing to retrieve oocytes for fertility preservation in patients with acute myeloid leukemia: two cases of controlled ovarian stimulation using DuoStim with a literature review. Sekiguchi M; Ito A; Fukuda Y; Yoneyama M; Furui M; Nakaoka K; Umemura N; Hayashi Y; Tamaki Y; Katagiri Y; Nakata M Gynecol Endocrinol; 2023 Dec; 39(1):2217262. PubMed ID: 37271166 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]